StockData
CV Sciences, Inc. logo

CV Sciences, Inc. (CVSI) stock

CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$0.01−0.00 (-21.13%)

Close on Oct 19, 2026Market cap $2.53MP/E –Yield –

CV Sciences net income

Net income is the profit left for shareholders after every expense, interest and tax.

CV Sciences's net income for the twelve months ending Sep 30, 2026 was -$1.72M. For fiscal 2025 it was -$958.00K. The highest annual figure on record is $10.00M in fiscal 2018.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$958.00K–
FY2024Dec 31, 2024-$2.39M-177.2%
FY2023Dec 31, 2023$3.10M–
FY2022Dec 31, 2022-$8.21M–
FY2021Dec 31, 2021-$15.55M–
FY2020Dec 31, 2020-$22.28M–
FY2019Dec 31, 2019-$16.61M-266.1%
FY2018Dec 31, 2018$10.00M–
FY2017Dec 31, 2017-$4.90M–
FY2016Dec 31, 2016-$14.14M–
FY2015Dec 31, 2015-$12.23M–
FY2014Dec 31, 2014-$1.31M–
FY2013Dec 31, 2013-$2.30M–
FY2012Dec 31, 2012-$45.61K–
FY2011Dec 31, 2011-$90.18K–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$93.00K–
Q2 FY2026Jun 30, 2026-$775.00K–
Q1 FY2026Mar 31, 2026-$643.00K–
Q4 FY2025Dec 31, 2025-$206.00K–
Q3 FY2025Sep 30, 2025-$382.00K–
Q2 FY2025Jun 30, 2025-$261.00K–
Q1 FY2025Mar 31, 2025-$109.00K–
Q4 FY2024Dec 31, 2024-$726.00K–
Q3 FY2024Sep 30, 2024-$456.00K–
Q2 FY2024Jun 30, 2024-$584.00K–
Q1 FY2024Mar 31, 2024-$628.00K-111.0%
Q4 FY2023Dec 31, 2023-$869.00K–
Q3 FY2023Sep 30, 2023-$447.00K–
Q2 FY2023Jun 30, 2023-$1.29M–
Q1 FY2023Mar 31, 2023$5.71M–
Q4 FY2022Dec 31, 2022-$2.31M–
Q3 FY2022Sep 30, 2022-$1.03M–
Q2 FY2022Jun 30, 2022-$2.65M–
Q1 FY2022Mar 31, 2022-$2.22M–
Q4 FY2021Dec 31, 2021-$8.86M–
Q3 FY2021Sep 30, 2021-$40.00K–
Q2 FY2021Jun 30, 2021-$3.53M–
Q1 FY2021Mar 31, 2021-$3.13M–
Q4 FY2020Dec 31, 2020-$9.29M–
Q3 FY2020Sep 30, 2020-$3.16M–
Q2 FY2020Jun 30, 2020-$4.68M-480.9%
Q1 FY2020Mar 31, 2020-$5.15M–
Q4 FY2019Dec 31, 2019-$6.69M-330.5%
Q3 FY2019Sep 30, 2019-$1.77M-153.7%
Q2 FY2019Jun 30, 2019$1.23M-61.4%
Q1 FY2019Mar 31, 2019-$9.38M-1616.0%
Q4 FY2018Dec 31, 2018$2.90M+517.3%
Q3 FY2018Sep 30, 2018$3.30M–
Q2 FY2018Jun 30, 2018$3.19M–
Q1 FY2018Mar 31, 2018$619.00K–
Q4 FY2017Dec 31, 2017$469.95K–
Q3 FY2017Sep 30, 2017-$589.98K–
Q2 FY2017Jun 30, 2017-$992.19K–
Q1 FY2017Mar 31, 2017-$3.78M–
Q4 FY2016Dec 31, 2016-$8.48M–

More CV Sciences figures

See a number that looks wrong?